The potential of GHK as an anti-aging peptide * Corresponding author: Warren Ladiges Mailing address: Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA 98195, USA
Observational data from practitioner-supervised use, even informal, contribute to the pre-clinical-to-clinical evidence bridge that BPC-157 currently lacks
BPC-157 stimulates fibroblast migration to the injury site and enhances the production of type I collagen, which is critical for restoring tendon and ligament strength
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
Reconstituted semaglutide should be used within 28 days of mixing
GHK-Cu stimulates fibroblasts to produce collagen types I and III, glycosaminoglycans, and decorin